Lisdexamfetamine is a prodrug, meaning it is converted into an active form within the body. The active ingredient in lisdexamfetamine dimesylate is dextroamphetamine [1]. It is formulated as an oral capsule or tablet.
What is Lisdexamfetamine Dimesylate Made Of?
The active ingredient in lisdexamfetamine dimesylate is dextroamphetamine [1]. The drug is available in capsule and tablet forms.
How Does Lisdexamfetamine Work?
Lisdexamfetamine itself is inactive. Once ingested, it is broken down in the gastrointestinal tract and during absorption into the bloodstream. This process releases dextroamphetamine, which then exerts its therapeutic effects [1]. Dextroamphetamine is a central nervous system stimulant that increases the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain.
What Are the Ingredients in Vyvanse?
Vyvanse is a brand name for lisdexamfetamine dimesylate [2]. The active ingredient is lisdexamfetamine dimesylate, which is converted to dextroamphetamine in the body [1]. The inactive ingredients in Vyvanse capsules may include microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and gelatin capsules that contain titanium dioxide and coloring agents [3].
When Does Lisdexamfetamine Patent Expiry?
Information regarding specific patent expiry dates for lisdexamfetamine can be found on specialized databases. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including lisdexamfetamine [4].
What Are the Risks of Taking Lisdexamfetamine?
Lisdexamfetamine carries potential risks, including serious cardiovascular events, psychiatric adverse reactions, and potential for abuse and dependence [1]. It can also cause side effects such as insomnia, decreased appetite, dry mouth, and weight loss [2]. Patients with certain pre-existing conditions may be at higher risk [1].